Idexx Laboratories (IDXX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 192,135 | 181,951 | 187,794 | 178,287 | 161,754 |
| Depreciation Amortization | 70,388 | 58,888 | 54,596 | 52,408 | 48,202 |
| Income taxes - deferred | 5,143 | 830 | 2,073 | -1,970 | 5,996 |
| Accounts receivable | -50,142 | -3,626 | -15,946 | 3,487 | -24,809 |
| Accounts payable and accrued liabilities | -2,468 | 6,703 | -4,399 | -2,898 | 13,015 |
| Other Working Capital | -64,373 | -9,719 | -3,063 | -5,611 | 3,544 |
| Other Operating Activity | 71,119 | 819 | 24,941 | -1,295 | 10,211 |
| Operating Cash Flow | $221,802 | $235,846 | $245,996 | $222,408 | $217,913 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -215,183 | N/A | N/A | N/A | N/A |
| PPE Investments | -82,921 | -55,123 | -77,612 | -57,573 | -49,452 |
| Net Acquisitions | -10,302 | -25,115 | -7,423 | 342 | -43,757 |
| Purchase Sale Intangibles | 0 | -175 | -1,024 | -900 | -1,000 |
| Other Investing Activity | 0 | -175 | -1,024 | -900 | -1,000 |
| Investing Cash Flow | $-308,406 | $-80,413 | $-86,059 | $-58,131 | $-94,209 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 24,000 | 272,000 | 65,000 | -31,000 | 113,903 |
| Debt Issued | 250,097 | 200,000 | 150,000 | N/A | N/A |
| Common Stock Issued | 22,397 | 29,442 | 38,235 | 24,166 | 28,801 |
| Common Stock Repurchased | -407,419 | -618,158 | -367,761 | -132,268 | -255,505 |
| Other Financing Activity | 9,935 | 13,278 | 12,075 | 13,759 | 15,144 |
| Financing Cash Flow | $-100,990 | $-103,438 | $-102,451 | $-125,343 | $-97,657 |
| Exchange Rate Effect | -5,948 | -8,517 | -2,414 | 1,157 | 933 |
| Beginning Cash Position | 322,536 | 279,058 | 223,986 | 183,895 | 156,915 |
| End Cash Position | 128,994 | 322,536 | 279,058 | 223,986 | 183,895 |
| Net Cash Flow | $-193,542 | $43,478 | $55,072 | $40,091 | $26,980 |
| Free Cash Flow | |||||
| Operating Cash Flow | 221,802 | 235,846 | 245,996 | 222,408 | 217,913 |
| Capital Expenditure | -82,921 | -60,523 | -77,612 | -57,618 | -49,677 |
| Free Cash Flow | 138,881 | 175,323 | 168,384 | 164,790 | 168,236 |